Perspectives on Adherence from the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach with 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment
Related Posts
Malhotra S, Adachi K, Fallah A, Johnson R, Ishminder Kaur, McCarty J, Ross L, Krogstad P. Pearls and Pitfalls of Intrathecal Amphotericin B Therapy for[...]
No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV
Erlandson KM, McKhann A, Kitch DW, Palella FJ, Ellis RJ, Ances BM, Zanni MV, Diggs MR, Chu SM, Currier JS, Bloomfield GS, Malvestutto CD, Fichtenbaum[...]
Kulik GL, Umbleja T, Brown TT, Ribaudo HJ, Grinspoon SK, Schrack JA, Zanni MV, Diggs MR, Aberg JA, Fichtenbaum CJ, Malvestutto CD, Chu SM, Currier[...]